EZH2 and Ewing sarcoma: To investigate whether EZH2 inhibition induces GD2 expression in OS, as previously described in Ewing sarcoma,16 we incubated Saos‐2 and HOS cells with increasing concentrations of the EZH2 inhibitor tazemetostat and analyzed GD2 surface expression on days 7 and 14.